About Proteona
Proteona is a company based in Singapore (Singapore) founded in 2016 by Jonathan Adam Scolnick was acquired by Singleron in March 2022. Proteona offers products and services including MobiuSCOPE, PythoN i™, and Tensor. Proteona operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Singapore, Singapore
- Founders Jonathan Adam Scolnick
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Proteona Pte. Ltd
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Proteona
Proteona offers a comprehensive portfolio of products and services, including MobiuSCOPE, PythoN i™, and Tensor.
Kit for full length single cell RNA sequencing applications
System for processing tissues for single cell analysis
Automated instrument for single cell library preparation
Funding Insights of Proteona
Detailed funding history for Proteona
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Proteona
Proteona has secured backing from 1 investor. Prominent investors backing the company include Singleron.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis
|
Locked | Locked | Locked |
Investor details for Proteona
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Proteona
Investment portfolio details for Proteona
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Proteona
Detailed financials for Proteona
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Proteona Comparisons
Peer comparison for Proteona
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Proteona
Proteona operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases are developed to treat patients.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Provider of cell therapies to treat cancer and hematologic conditions
|
Detailed competitors of Proteona
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Proteona
Complete news archive for Proteona
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Proteona
Proteona was founded in 2016.
Proteona is headquartered in Singapore, Singapore.
Annual revenue of Proteona is $268.36K as on Dec 31, 2019.
Proteona was established in 2016 in Singapore within the biotechnology sector. Therapeutics grounded in single cell proteogenomics are offered, with operations focused on advanced cellular analysis. The ESCAPE Technology platform is employed for protein expression profiling at the single cell level. This suite of technologies relies on DNA barcoded antibodies to enable detailed proteogenomic insights. Key leadership includes co-founder Jonathan Adam Scolnick and executive director Charles Goldstein.
Proteona's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Proteona offers MobiuSCOPE, PythoN i™, and Tensor.
Proteona has 1 investor. Key investors include Singleron.